Simone M Sint Nicolaas1, Sasja A Schepers2, Peter M Hoogerbrugge3, Huib N Caron4, Gertjan J L Kaspers5, Marry M van den Heuvel-Eibrink6, Martha A Grootenhuis2, Chris M Verhaak7. 1. Radboud University Medical Center, Nijmegen, the Netherlands, Simone.SintNicolaas@radboudumc.nl. 2. Emma Children's Hospital Academic Medical Center, Amsterdam, the Netherlands, Princess Máxima Center for Pediatric Oncology, the Bilt, the Netherlands. 3. Radboud University Medical Center, Nijmegen, the Netherlands, Princess Máxima Center for Pediatric Oncology, the Bilt, the Netherlands. 4. Radboud University Medical Center, Nijmegen, the Netherlands, Roche, Basel, Switzerland. 5. Princess Máxima Center for Pediatric Oncology, the Bilt, the Netherlands, VU University Medical Center, Amsterdam, the Netherlands, and. 6. Princess Máxima Center for Pediatric Oncology, the Bilt, the Netherlands, Sophia Children's Hospital Erasmus Medical Center, Rotterdam, the Netherlands. 7. Radboud University Medical Center, Nijmegen, the Netherlands.
Abstract
OBJECTIVE: The Psychosocial Assessment Tool (PAT) was developed to screen for psychosocial risk in families of a child diagnosed with cancer. The current study is the first describing the cross-cultural adaptation, reliability, validity, and usability of the PAT in an European country (Dutch translation). METHODS: A total of 117 families (response rate 59%) of newly diagnosed children with cancer completed the PAT2.0 and validation measures. RESULTS: Acceptable reliability was obtained for the PAT total score (α = .72) and majority of subscales (0.50-0.82). Two subscales showed inadequate internal consistency (Social Support α = .19; Family Beliefs α = .20). Validity and usability were adequate. Of the families, 66% scored low (Universal), 29% medium (Targeted), and 5% high (Clinical) risk. CONCLUSIONS: This study confirms the cross-cultural applicability, reliability, and validity of the PAT total score. Reliability left room for improvement on subscale level. Future research should indicate whether the PAT can be used to provide cost-effective care.
OBJECTIVE: The Psychosocial Assessment Tool (PAT) was developed to screen for psychosocial risk in families of a child diagnosed with cancer. The current study is the first describing the cross-cultural adaptation, reliability, validity, and usability of the PAT in an European country (Dutch translation). METHODS: A total of 117 families (response rate 59%) of newly diagnosed children with cancer completed the PAT2.0 and validation measures. RESULTS: Acceptable reliability was obtained for the PAT total score (α = .72) and majority of subscales (0.50-0.82). Two subscales showed inadequate internal consistency (Social Support α = .19; Family Beliefs α = .20). Validity and usability were adequate. Of the families, 66% scored low (Universal), 29% medium (Targeted), and 5% high (Clinical) risk. CONCLUSIONS: This study confirms the cross-cultural applicability, reliability, and validity of the PAT total score. Reliability left room for improvement on subscale level. Future research should indicate whether the PAT can be used to provide cost-effective care.
Authors: Christina M Sharkey; Sasja A Schepers; Sarah Drake; Ahna L H Pai; Larry L Mullins; Martha A Grootenhuis Journal: J Pediatr Psychol Date: 2020-05-01
Authors: Sasja A Schepers; Simone M Sint Nicolaas; Heleen Maurice-Stam; Elisabeth M van Dijk-Lokkart; Esther M M van den Bergh; Nienke de Boer; Chris M Verhaak; Martha A Grootenhuis Journal: Support Care Cancer Date: 2017-05-11 Impact factor: 3.603